Erythematotelangiectatic rosacea
Conditions
Interventions
Dye laser group:none
Mid infrared group:none
Intense Pulsed Light group:none
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.According to the 2021 Chinese Diagnostic Criteria for Rosacea, diagnosed as erythematotelangiectatic rosacea; 2.Aged 18-55 years, Fitzpatrick skin types III-IV; 3.The medical history and clinical data are complete (including energy/pulse width/laser spot parameters), with thorough treatment and follow-up records, and complete photographic documentation.
Exclusion criteria
Exclusion criteria: 1.Combined with other skin diseases that affect the research results, such as eczema, psoriasis, systemic lupus Eratosthenes or dermatologists. 2.There are serious basic diseases that affect treatment and recovery, such as diabetes (poor blood sugar control), immune deficiency, and severe liver and kidney dysfunction; 3.Other drugs (such as oral isotretinoin, antibiotics), topical hormones or other photoelectric therapy were used for the treatment of erythema telangiectasia within 3 months before the start of treatment. 4.patients with an incomplete treatment course.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Erythema Assessment Scale (CEA) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Self Assessment Form (PSA); | — |
Countries
China
Contacts
Public ContactGe Lan
The First Affiliated Hospital of Army Medical University
Outcome results
None listed